1. From the Department of Urology, Johannes Gutenberg University Medical School, Mainz, West Germany
2. Biological Therapeutics Branch, Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute, NIH, Frederick Cancer Research Facility, Frederick, Maryland